<p>The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof for treating diseases and conditions mediated by positive allosteric modulation of the G- protein coupled metabotropic subtype 5 receptor (mGluR5), such as neurological and psychiatric disorders, for example schizophrenia. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.</p>
申请公布号
WO2008152089(A1)
申请公布日期
2008.12.18
申请号
WO2008EP57373
申请日期
2008.06.12
申请人
GLAXO GROUP LIMITED;GIANOTTI, MASSIMO;LOVELL, PETER, JOHN;SERI, CATIA;TEHAN, BENJAMIN, GERALD